Senzime AB (OSTO:SEZI) Accounts Payable : kr8.92 Mil (As of Mar. 2025)

View and export this data going back to 2008. Start your Free Trial

What is Senzime AB Accounts Payable?

Senzime AB's Accounts Payable for the quarter that ended in Mar. 2025 was kr8.92 Mil.

Senzime AB's quarterly Accounts Payable increased from Sep. 2024 (kr7.65 Mil) to Dec. 2024 (kr8.88 Mil) and increased from Dec. 2024 (kr8.88 Mil) to Mar. 2025 (kr8.92 Mil).

Senzime AB's annual Accounts Payable declined from Dec. 2022 (kr7.32 Mil) to Dec. 2023 (kr5.15 Mil) but then increased from Dec. 2023 (kr5.15 Mil) to Dec. 2024 (kr8.88 Mil).

Senzime AB Accounts Payable Historical Data

The historical data trend for Senzime AB's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Senzime AB Accounts Payable Chart

Senzime AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable

Get a 7-Day Free Trial

4.72

3.94

7.32

5.15

8.88

Senzime AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable	Get a 7-Day Free Trial															5.35	7.78	7.65	8.88	8.92

Senzime AB Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Senzime AB Accounts Payable Related Terms

Thank you for viewing the detailed overview of Senzime AB's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Senzime AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Senzime AB (OSTO:SEZI) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

SNZZF:USA

Address

Verkstadsgatan 8, Uppsala, SWE, 753 23

Website

https://www.senzime.com

Senzime AB is a medical device company providing patient monitoring systems. Its portfolio comprises systems for patient monitoring of neuromuscular function and breathing, typically during and after surgery, and for the intensive care sector. TetraGraph is a system based on EMG technology for neuromuscular monitoring during surgical procedures. ExSpiron 2Xi is a non-invasive monitoring system of respiratory volume and minute ventilation used for in and out patient care. The company operates in Sweden, Germany and the USA. It derives revenue through sales of monitors and associated disposable sensors to hospitals and clinics.

Senzime AB Headlines

No Headlines